Developer docs
API playgroundTry for free, no card

Search company profiles

Tokyo Future Style

Full company profile

uuid002qbhn

Namestring
Tokyo Future Style
Legal namestring
株式会社東京未来スタイル
Company typeenum
Private
Founded yearint
2007
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersTsukuba, Japan
HQ citystring
Tsukuba
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science reagents, research reagent distribution, biotech trading company, import export services, research material procurement
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Life Science Reagent Distribution
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Research reagent import and distribution
TypeOne Time License
Description

Tokyo Future Style operates as a life science trading company, importing and distributing research reagents, antibodies, recombinant proteins, ELISA kits, magnetic beads, cell tracking reagents, and clinical samples from global biotech suppliers to Japanese and Asian research institutions. Revenue is generated through product sales, distribution agreements, and trading/import-export services.

tokyofuturestyle.com
2Custom synthesis and research services
TypeProfessional Services
Description

The company offers custom synthesis services and research outsourcing, including procurement of specialized research materials. Revenue is generated through service fees.

tokyofuturestyle.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Tokyo Future Style is a life science trading company that imports and distributes research reagents, antibodies, recombinant proteins, ELISA kits, magnetic beads, cell tracking reagents, and human clinical samples from global biotech suppliers to research institutions across Japan, Taiwan, and Europe. The company also offers custom synthesis services, research material procurement, and contract research support, acting as an intermediary between Western/Asian bio-venture suppliers and Japanese/Asian life science customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Tokyo Future Style is a life science trading company that imports and distributes research reagents, materials, and custom services from global biotech suppliers. The company operates a multi-product portfolio organized into eight main categories: infectious disease, cancer research, regenerative medicine, drug discovery, life science products, NAMs (New Approach Methodologies), human clinical samples, and custom synthesis services. Key branded products include LuminX Tracking Kits for fluorescent nanodiamond-based in vivo cell tracking, and MAGicBeads/MAGicSep magnetic bead purification and separation systems. The company also distributes products from over 20 international suppliers including ACROBiosystems, ICE Bioscience, Abbexa, and SinoBiological. Services include research material procurement, custom synthesis, and contract research support across Japan, Taiwan, and Europe.

Product and service6 records
1LuminX Tracking Kit (LTK)
CategoryLife Science Research Reagent
Description

Fluorescent nanodiamond-based cell tracking kit using proprietary XTag technology for in vivo tracking of MSC, iPSC, T cells, NK cells, and cancer cells. Designed for life science researchers and cell therapy developers.

2MAGicBeads Magnetic Beads
CategoryBioprocessing Reagent
Description

Magnetic agarose beads for antibody purification and cell separation, including MAGicBeads mAb (alkali-resistant Protein A), MAGicBeads PrtA, MAGicBeads SerA, and MAGicBeads ACT (activated beads for custom coupling). For bioprocessing and antibody research customers.

3MAGicSep Magnetic Separators
CategoryBioprocessing Equipment
Description

Magnetic separation devices including MAGicSep LAB, PILOT (50/500), and PROCESS (Compact/Medio/Maxi) units for lab to process-scale throughput. Targeted at bioprocessing and antibody production customers.

4Custom Synthesis and Contract Research Services
CategoryResearch Services
Description

Contract research services including custom synthesis of compounds, custom magnetic bead development, and outsourced laboratory services for life science researchers and pharmaceutical/biotech companies.

5Research Material Procurement Service
CategoryProcurement Services
Description

Sourcing and procurement service for specialized research reagents and materials from global biotech suppliers on behalf of Japanese and Asian research institutions. Includes logistics, regulatory navigation, and translation support for cross-border procurement.

6EMARS Reagent Ar-Flu
CategoryLife Science Research Reagent
Description

Research reagent that enables detection of molecular interactions on living cell membranes with high selectivity and improved detection efficiency through HRP reaction. Targeted at academic and industrial life science researchers studying cell surface interactions.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-21
Description

Tokyo Future Style showcases Finnadvance's MPS (Microphysiological Systems) device AKITA and NAMs-related products at the MPS Council 3rd Academic Symposium (January 2025).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-11
Description

Tokyo Future Style and Netguard Technology Co., Ltd. established a joint venture company in Taiwan in January 2019. The joint venture aims to provide import services for products suitable for the Taiwanese biological research market and export services for Taiwanese companies' products to global markets.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-04-21
Description

TFS Europe B.V. is a 100% subsidiary of Tokyo Future Style established in Nijmegen, the Netherlands, in April 2017. It serves as the company's European hub for import/export of life science research materials.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-04-20
Description

Tokyo Future Style signed a distribution agreement with Radboud University Medical Center for Japan and Taiwan. The agreement covers transporter assay and drug toxicity screening applications using human renal cell lines developed by the university.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2016-11-04
Description

Tokyo Future Style signed a distribution agreement for Japan and Taiwan with TropIQ Health Sciences, a Dutch bio-venture company. The agreement covers novel technologies useful for anti-malaria drug development and insecticide development.

6UAB Ferentis (Lithuania)
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2016-06-10
Description

Tokyo Future Style signed a distribution agreement for Japan with UAB Ferentis, a Lithuanian bio-venture company, to distribute the company's hydrogel-related products.

en.tokyofuturestyle.com
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2015-05-27
Description

Tokyo Future Style signed a distribution agreement with KromaTiD, a US chromosomal/genetic testing venture company, to distribute their products in Japan.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Funakoshi Co., Ltd.
TypeDirect peer
Description

Japanese life science reagent distributor/trading company importing research reagents, antibodies, and kits to Japanese researchers. Direct comparable to TFS in business model, customer base (Japanese academic/biotech R&D), and catalog breadth.

2Nacalai Tesque, Inc.
TypeDirect peer
Description

Kyoto-based Japanese life sciences reagent manufacturer and distributor serving academic and biotech researchers in Japan. Comparable to TFS in its reagent distribution and import activities for research customers.

TypeDirect peer
Description

China/US-headquartered recombinant protein and reagent supplier using HEK293 platform. Distributed by TFS in Japan; comparable as an Asian bio-venture reagent supplier with overlapping catalog in drug discovery and cell therapy reagents.

TypeBroad incumbent
Description

Global life science tools and reagent giant with extensive catalog and direct Japanese operations. Overlaps with TFS in reagent distribution to Japanese researchers but at vastly larger scale and broader offering.

TypeDirect peer
Description

Beijing-headquartered recombinant protein and antibody supplier for research use. TFS actually distributes SinoBiological products in Japan/Taiwan, making them a key supplier relationship; comparable as a global bio-venture reagent company targeting Asian research customers.

TypeBroad incumbent
Description

Major Japanese chemical and reagent brand serving life science research with a much broader catalog and scale. Overlaps with TFS in life science reagent distribution in Japan but operates as a much larger established player with manufacturing capabilities.

TypeBroad incumbent
Description

Large global life science reagent, antibody, and protein supplier (R&D Systems, Tocris, ProteinSimple brands). Overlaps with TFS in reagents/antibodies/proteins distribution but operates at vastly greater scale and across broader geographies.

TypeBroad incumbent
Description

Global life science research and clinical diagnostics company with significant reagent offering. Comparable to TFS in protein/antibody/reagent distribution to researchers but at broader scale and with product manufacturing rather than pure trading.

9Cosmo Bio Co., Ltd.
TypeDirect peer
Description

Tokyo-based life science reagent distributor serving Japanese research institutions with imported and proprietary products. Closest direct peer to TFS given shared Japanese customer base, import/distribution model, and reagent portfolio focus.

TypeDirect peer
Description

Global biotech with strong presence in Asia providing gene synthesis, proteins, antibodies, and cell therapy services. Comparable to TFS given Asian orientation and life science research product portfolio serving biotech R&D customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tokyo Future Style

Life Science Reagent Distributiontokyofuturestyle.com

Tokyo Future Style firmographics

Firmographics
Name
Tokyo Future Style
Legal name
株式会社東京未来スタイル
Website
https://tokyofuturestyle.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where Tokyo Future Style is headquartered

Location

Headquarters

HQ city
Tsukuba
HQ country
Japan
HQ region
Asia

Offices3 records

Markets served

Tokyo Future Style business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Research reagent import and distribution: Tokyo Future Style operates as a life science trading company, importing and distributing research reagents, antibodies, recombinant proteins, ELISA kits, magnetic beads, cell tracking reagents, and clinical samples from global biotech suppliers to Japanese and Asian research institutions. Revenue is generated through product sales, distribution agreements, and trading/import-export services.
  2. Custom synthesis and research services: The company offers custom synthesis services and research outsourcing, including procurement of specialized research materials. Revenue is generated through service fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Tokyo Future Style product offering

Product offering

Core offering

Tokyo Future Style is a life science trading company that imports and distributes research reagents, antibodies, recombinant proteins, ELISA kits, magnetic beads, cell tracking reagents, and human clinical samples from global biotech suppliers to research institutions across Japan, Taiwan, and Europe. The company also offers custom synthesis services, research material procurement, and contract research support, acting as an intermediary between Western/Asian bio-venture suppliers and Japanese/Asian life science customers.

Product overview

Tokyo Future Style is a life science trading company that imports and distributes research reagents, materials, and custom services from global biotech suppliers. The company operates a multi-product portfolio organized into eight main categories: infectious disease, cancer research, regenerative medicine, drug discovery, life science products, NAMs (New Approach Methodologies), human clinical samples, and custom synthesis services. Key branded products include LuminX Tracking Kits for fluorescent nanodiamond-based in vivo cell tracking, and MAGicBeads/MAGicSep magnetic bead purification and separation systems. The company also distributes products from over 20 international suppliers including ACROBiosystems, ICE Bioscience, Abbexa, and SinoBiological. Services include research material procurement, custom synthesis, and contract research support across Japan, Taiwan, and Europe.

Differentiator

Problem solved

Functional benefit

Products and services

  • LuminX Tracking Kit (LTK) Fluorescent nanodiamond-based cell tracking kit using proprietary XTag technology for in vivo tracking of MSC, iPSC, T cells, NK cells, and cancer cells. Designed for life science researchers and cell therapy developers.
  • MAGicBeads Magnetic Beads Magnetic agarose beads for antibody purification and cell separation, including MAGicBeads mAb (alkali-resistant Protein A), MAGicBeads PrtA, MAGicBeads SerA, and MAGicBeads ACT (activated beads for custom coupling). For bioprocessing and antibody research customers.
  • MAGicSep Magnetic Separators Magnetic separation devices including MAGicSep LAB, PILOT (50/500), and PROCESS (Compact/Medio/Maxi) units for lab to process-scale throughput. Targeted at bioprocessing and antibody production customers.
  • Custom Synthesis and Contract Research Services Contract research services including custom synthesis of compounds, custom magnetic bead development, and outsourced laboratory services for life science researchers and pharmaceutical/biotech companies.
  • Research Material Procurement Service Sourcing and procurement service for specialized research reagents and materials from global biotech suppliers on behalf of Japanese and Asian research institutions. Includes logistics, regulatory navigation, and translation support for cross-border procurement.
  • EMARS Reagent Ar-Flu Research reagent that enables detection of molecular interactions on living cell membranes with high selectivity and improved detection efficiency through HRP reaction. Targeted at academic and industrial life science researchers studying cell surface interactions.

Companies that use Tokyo Future Style

Customer profile

Segments2 records

Ideal customer profiles2 records

Tokyo Future Style technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Tokyo Future Style partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor, core and major.

  • Finnadvance (MPS device AKITA and NAMs related products)minorChannel Partner/ Reseller/ Distributor · 21 January 2025Tokyo Future Style showcases Finnadvance's MPS (Microphysiological Systems) device AKITA and NAMs-related products at the MPS Council 3rd Academic Symposium (January 2025).
  • Netguard Technology Co., Ltd. (網護科技)coreStrategic or Co-development Partner · 11 January 2019Tokyo Future Style and Netguard Technology Co., Ltd. established a joint venture company in Taiwan in January 2019. The joint venture aims to provide import services for products suitable for the Taiwanese biological research market and export services for Taiwanese companies' products to global markets.
  • TFS Europe B.V.coreChannel Partner/ Reseller/ Distributor · 21 April 2017TFS Europe B.V. is a 100% subsidiary of Tokyo Future Style established in Nijmegen, the Netherlands, in April 2017. It serves as the company's European hub for import/export of life science research materials.
  • Radboud University Medical Center (Nijmegen, Netherlands)majorChannel Partner/ Reseller/ Distributor · 20 April 2017Tokyo Future Style signed a distribution agreement with Radboud University Medical Center for Japan and Taiwan. The agreement covers transporter assay and drug toxicity screening applications using human renal cell lines developed by the university.
  • TropIQ Health Sciences (Netherlands)majorChannel Partner/ Reseller/ Distributor · 4 November 2016Tokyo Future Style signed a distribution agreement for Japan and Taiwan with TropIQ Health Sciences, a Dutch bio-venture company. The agreement covers novel technologies useful for anti-malaria drug development and insecticide development.
  • UAB Ferentis (Lithuania)majorChannel Partner/ Reseller/ Distributor · 10 June 2016Tokyo Future Style signed a distribution agreement for Japan with UAB Ferentis, a Lithuanian bio-venture company, to distribute the company's hydrogel-related products.
  • KromaTiD (USA)majorChannel Partner/ Reseller/ Distributor · 27 May 2015Tokyo Future Style signed a distribution agreement with KromaTiD, a US chromosomal/genetic testing venture company, to distribute their products in Japan.

Scale indicators1 record

Recent moves10 records

Expansion highlights5 records

Tokyo Future Style competitors and assessment

Company assessment

Direct peers

  • Funakoshi Co., Ltd. Japanese life science reagent distributor/trading company importing research reagents, antibodies, and kits to Japanese researchers. Direct comparable to TFS in business model, customer base (Japanese academic/biotech R&D), and catalog breadth.
  • Nacalai Tesque, Inc. Kyoto-based Japanese life sciences reagent manufacturer and distributor serving academic and biotech researchers in Japan. Comparable to TFS in its reagent distribution and import activities for research customers.
  • ACROBiosystems: China/US-headquartered recombinant protein and reagent supplier using HEK293 platform. Distributed by TFS in Japan; comparable as an Asian bio-venture reagent supplier with overlapping catalog in drug discovery and cell therapy reagents.
  • Sino Biological, Inc. Beijing-headquartered recombinant protein and antibody supplier for research use. TFS actually distributes SinoBiological products in Japan/Taiwan, making them a key supplier relationship; comparable as a global bio-venture reagent company targeting Asian research customers.
  • Cosmo Bio Co., Ltd. Tokyo-based life science reagent distributor serving Japanese research institutions with imported and proprietary products. Closest direct peer to TFS given shared Japanese customer base, import/distribution model, and reagent portfolio focus.
  • GenScript Biotech: Global biotech with strong presence in Asia providing gene synthesis, proteins, antibodies, and cell therapy services. Comparable to TFS given Asian orientation and life science research product portfolio serving biotech R&D customers.

Broad incumbents

  • Thermo Fisher Scientific: Global life science tools and reagent giant with extensive catalog and direct Japanese operations. Overlaps with TFS in reagent distribution to Japanese researchers but at vastly larger scale and broader offering.
  • FUJIFILM Wako Pure Chemical: Major Japanese chemical and reagent brand serving life science research with a much broader catalog and scale. Overlaps with TFS in life science reagent distribution in Japan but operates as a much larger established player with manufacturing capabilities.
  • Bio-Techne Corporation: Large global life science reagent, antibody, and protein supplier (R&D Systems, Tocris, ProteinSimple brands). Overlaps with TFS in reagents/antibodies/proteins distribution but operates at vastly greater scale and across broader geographies.
  • Bio-Rad Laboratories: Global life science research and clinical diagnostics company with significant reagent offering. Comparable to TFS in protein/antibody/reagent distribution to researchers but at broader scale and with product manufacturing rather than pure trading.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Tokyo Future Style social profiles

Digital presence

Tokyo Future Style financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tokyo Future Style leadership team

Management profile

Number of profiles

Profiles1 record

Tokyo Future Style subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Tokyo Future Style funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tokyo Future Style M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tokyo Future Style

What does Tokyo Future Style do?

Tokyo Future Style is a life science trading company that imports and distributes research reagents, antibodies, recombinant proteins, ELISA kits, magnetic beads, cell tracking reagents, and human clinical samples from global biotech suppliers to research institutions across Japan, Taiwan, and Europe. The company also offers custom synthesis services, research material procurement, and contract research support, acting as an intermediary between Western/Asian bio-venture suppliers and Japanese/Asian life science customers.

Is Tokyo Future Style a public or private company?

Tokyo Future Style is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Tokyo Future Style founded?

Tokyo Future Style was founded in 2007. It employs 1 to 10 people.

Where is Tokyo Future Style based?

Tokyo Future Style is headquartered in Tsukuba, Japan, in the Asia region.

How does Tokyo Future Style make money?

Two revenue lines are on record. Research reagent import and distribution is the primary driver. The others are custom synthesis and research services.

Who are Tokyo Future Style's main competitors?

Direct peers on record are Funakoshi Co., Ltd., Nacalai Tesque, Inc., ACROBiosystems, Sino Biological, Inc., Cosmo Bio Co., Ltd. and GenScript Biotech. Broad incumbents are Thermo Fisher Scientific, FUJIFILM Wako Pure Chemical, Bio-Techne Corporation and Bio-Rad Laboratories.

Does Tokyo Future Style have an API?

No public API is recorded for Tokyo Future Style.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals